Price movement over the last 24 hours
Abeona Therapeutics Inc vs Abercrombie & Fitch Co. — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Abercrombie & Fitch Co. trades at $87 (market cap $3.96B). The key difference: Abercrombie & Fitch Co. is far larger — about 10.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Abercrombie & Fitch Co. nearer its low. Which is the better fit depends on your goals.
| ABEO | ANF | |
|---|---|---|
Market Cap | $373.32M | $3.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.23 | $129.85 |
52-Week Low | $4.17 | $65.61 |
Enterprise Value | $228.22M | $4.63B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →